Martina Iovine

Employment

• Istituto Nazionale Tumori IRCCS Fondazione Pascale Researcher/Student
  2020 - Present

Education

• Università degli Studi di Napoli Federico II LM Scienze Biologiche - Diagnostica Molecolare
  2008 - 2018

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Atrial Fibrillation and Cancer: Pathophysiological Mechanism and Clinical Implications
  Journal of Clinical Medicine 2025 DOI: 10.3390/jcm14155600
  +Save
• PCSK9 Inhibitor Inclisiran Attenuates Cardiotoxicity Induced by Sequential Anthracycline and Trastuzumab Exposure via NLRP3 and MyD88 Pathway Inhibition
  International Journal of Molecular Sciences 2025 DOI: 10.3390/ijms26146617
  +Save
• Glucagon-like Peptide 1 Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer Patients
  International Journal of Molecular Sciences 2024 DOI: 10.3390/ijms252011299
  +Save
• The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer Patients
  Cancers 2024 DOI: 10.3390/cancers16081487
  +Save
• PCSK9 Inhibitors in Cancer Patients Treated with Immune-Checkpoint Inhibitors to Reduce Cardiovascular Events: New Frontiers in Cardioncology
  Cancers 2023 DOI: 10.3390/cancers15051397
  +Save
• SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients
  Cancers 2020 DOI: 10.3390/cancers12113316
  +Save
• Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models
  Journal of Personalized Medicine 2020 DOI: 10.3390/jpm10040179
  +Save